EagleClaw Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,750
| Closed | -$253K | – | 120 |
|
|
2018
Q3 | $253K | Sell |
11,750
-100
| -0.8% | -$2.15K | 0.11% | 107 |
|
|
2018
Q2 | $287K | Sell |
11,850
-500
| -4% | -$12.1K | 0.14% | 98 |
|
|
2018
Q1 | $212K | Sell |
12,350
-1,200
| -9% | -$20.6K | 0.11% | 109 |
|
|
2017
Q4 | $258K | Sell |
13,550
-1,925
| -12% | -$36.7K | 0.13% | 102 |
|
|
2017
Q3 | $271K | Sell |
15,475
-1,000
| -6% | -$17.5K | 0.15% | 98 |
|
|
2017
Q2 | $545K | Hold |
16,475
| – | – | 0.32% | 75 |
|
|
2017
Q1 | $529K | Hold |
16,475
| – | – | 0.32% | 77 |
|
|
2016
Q4 | $600K | Sell |
16,475
-1,000
| -6% | -$36.4K | 0.38% | 70 |
|
|
2016
Q3 | $804K | Buy |
17,475
+8,075
| +86% | +$372K | 0.51% | 65 |
|
|
2016
Q2 | $471K | Sell |
9,400
-1,200
| -11% | -$60.1K | 0.31% | 78 |
|
|
2016
Q1 | $567K | Sell |
10,600
-9,126
| -46% | -$488K | 0.38% | 67 |
|
|
2015
Q4 | $1.3M | Sell |
19,726
-500
| -2% | -$32.9K | 0.86% | 44 |
|
|
2015
Q3 | $1.14M | Sell |
20,226
-50
| -0.2% | -$2.83K | 0.8% | 46 |
|
|
2015
Q2 | $1.2M | Sell |
20,276
-350
| -2% | -$20.8K | 0.77% | 49 |
|
|
2015
Q1 | $1.29M | Hold |
20,626
| – | – | 0.83% | 46 |
|
|
2014
Q4 | $1.19M | Hold |
20,626
| – | – | 0.78% | 48 |
|
|
2014
Q3 | $1.11M | Hold |
20,626
| – | – | 0.75% | 51 |
|
|
2014
Q2 | $1.08M | Hold |
20,626
| – | – | 0.73% | 50 |
|
|
2014
Q1 | $1.09M | Buy |
+20,626
| New | +$1.09M | 0.79% | 48 |
|